Search results
Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?
Investor's Business Daily· 1 day agoBut rather than stimulate another hormone, like Zepbound which also loops in GIP, MariTide actually...
Warren Buffett lost 'quite a bit of money' selling Berkshire Hathaway's stake in Paramount
Quartz· 4 hours agoDuring a question-and-answer session at Berkshire’s annual shareholder conference on Saturday,...
Ryan Garcia fails drug test. His opponent, Devin Haney, is connected to Victor Conte.
USA TODAY Sports via Yahoo Sports· 2 days ago“Victor Conte’s Fighter Training Stack has brought me to the next level,’’ ...Porter. Conte said it...
New era for pot regulation leaves old problem: Many cannabis companies can’t find a bank
La Crosse Tribune· 8 hours agoThe Biden administration's move to reclassify marijuana as a less dangerous but still controlled ...
Lawsuit Funding Leader Launches New Page for Pharmaceutical Bad Drug Lawsuits
CW39 NewsFix· 3 days agoPre-Settlement Funding Firm has specialized in funding for pharmaceutical drug lawsuits for over a decade, and has an experienced team to handle high-intake requests for those ...
Analyst unveils Amgen stock price target after weight-loss drug data
TheStreet via Yahoo Finance· 1 day agoAnalysts react to Amgen's first-quarter results. Company 'confident' in obesity drug Amgen posted...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 4 days agoEli Lilly stock surged within striking distance of a breakout in late April after the company...
Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss Drug...
Barrons.com· 1 day agoFEATURE Amgen stock was on track for its biggest daily gain since 2009 after the company said it saw...
As the US moves to reclassify marijuana as a less dangerous drug, could more states legalize it?
The News-Times· 13 hours agoAs the U.S. government moves toward reclassifying marijuana as a less dangerous drug, there may be...
Obesity drug rivals aim to unseat Zepbound, Ozempic - Indianapolis Business Journal
Indianapolis Business Journal· 2 days agoInsatiable demand for weight-loss drugs has made the market so feverish that any positive mention of...